Harper Cancer Research Institute | September 7, 2015
With ovarian cancer ranking fifth in cancer deaths among women, there is an urgent need to increase research to improve early detection, develop new treatments and therapies, and methods for more effective imaging.
Currently, there is no reliable test to detect ovarian cancer in its earliest stages, so the majority of women with the disease are diagnosed after the tumor has already spread. Diagnosis in late stages of the disease dramatically reduces the effectiveness of current treatments and long-term survival.
Dr. Sharon Stack, Director of the Harper Cancer Research Institute, and her lab are working to change these outcomes.